Approval · Notice of Compliance 10123 · 2009
AZASITE: Notice of Compliance 10123
Issued March 27, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10123
- Date
- March 27, 2009
- Company
- Insite Vision IncorporatedAlameda, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Macrolide antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AZASITE | 02321661 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- AZITHROMYCIN 1 PER